NCT02242396View on ClinicalTrials.gov

A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

CompletedOBSERVATIONAL
Enrollment

5,248

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

November 30, 2007

Conditions
Hypertension
Interventions
DRUG

Telmisartan

DRUG

Telmisartan hydrochlorothiazide

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY